Literature DB >> 9217571

Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease.

R M Peek1, M J Blaser.   

Abstract

Helicobacter pylori causes persistent infection and inflammation in the human stomach, yet only a small fraction of persons harboring this organism develop peptic ulcer disease. An important question is why this variation in infection outcome exists. Recent studies have demonstrated that H pylori isolates possess substantial phenotypic and genotypic diversity that may engender differential host inflammatory responses that influence clinical outcome. Further investigation in this field may help to define which H pylori-infected persons bear the highest risk for subsequent development of peptic ulcer disease, and thus enable physicians to focus eradication therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9217571     DOI: 10.1016/s0002-9343(96)00273-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

Review 1.  Nontraditional therapies to treat Helicobacter pylori infection.

Authors:  Morris O Makobongo; Jeremy J Gilbreath; D Scott Merrell
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase.

Authors:  D Basso; F Navaglia; L Brigato; F Di Mario; M Rugge; M Plebani
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

3.  Serum ferritin, vitamin B(12), folate, and zinc levels in children infected with Helicobacter pylori.

Authors:  Mustafa Akcam; Sebahat Ozdem; Aygen Yilmaz; Meral Gultekin; Reha Artan
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

4.  Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.

Authors:  M Quiding-Järbrink; I Ahlstedt; C Lindholm; E L Johansson; H Lönroth
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

5.  Human gastric B cell responses can be induced by intestinal immunisation.

Authors:  M Quiding-Järbrink; H Lönroth; I Ahlstedt; J Holmgren; A M Svennerholm
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

6.  The histamine H3 receptor agonist N alpha-methylhistamine produced by Helicobacter pylori does not alter somatostatin release from cultured rabbit fundic D-cells.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

7.  Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway.

Authors:  J Houghton; R M Korah; M R Condon; K H Kim
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

8.  Helicobacter pylori and recurrent pain abdomen.

Authors:  Niranjan Biswal; N Ananathakrishnan; Vikram Kate; S Srinivasan; P Nalini; Betsy Mathai
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

9.  Local cytokine response in Helicobacter pylori-infected subjects.

Authors:  C Lindholm; M Quiding-Järbrink; H Lönroth; A Hamlet; A M Svennerholm
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  CD4+ and CD8+ T cell responses in Helicobacter pylori-infected individuals.

Authors:  M Quiding-Järbrink; B S Lundin; H Lönroth; A M Svennerholm
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.